Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
UK |
|
Banco Santander SA
MIL:SANT
|
ES |
|
Dometic Group AB (publ)
STO:DOM
|
SE |
|
Eat & Beyond Global Holdings Inc
OTC:EATBF
|
CA |
|
P
|
Pasukhas Group Bhd
KLSE:PASUKGB
|
MY |
|
LG Display Co Ltd
KRX:034220
|
KR |
|
C
|
Cords Cable Industries Ltd
NSE:CORDSCABLE
|
IN |
|
GTPL Hathway Ltd
BSE:540602
|
IN |
|
T
|
Tod's SpA
LSE:0NV4
|
IT |
|
J
|
Johnson & Johnson
BMV:JNJ
|
US |
Wall Street
Price Targets
CRNX Price Targets Summary
Crinetics Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CRNX
is 86.34 USD
with a low forecast of 55.55 USD and a high forecast of 110.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRNX's stock price target?
Price Target
86.34
USD
According to Wall Street analysts, the average 1-year price target for
CRNX
is 86.34 USD
with a low forecast of 55.55 USD and a high forecast of 110.25 USD.
What is Crinetics Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
281%
For the last 8 years the
compound annual growth rate for
Crinetics Pharmaceuticals Inc's revenue is
18%.
The projected
CAGR
for the next 3 years is
281%.
